Home » Topics » BioWorld Science, Biomarkers

BioWorld Science, Biomarkers
RSS

Quest Diagnostics launches molecular cervical cancer test

Sep. 3, 2012

Pathophysiological changes occur years before Alzheimer's disease symptoms develop

Sep. 3, 2012

New genetic test predicts response to antipsychotics/antidepressants

Aug. 31, 2012

Zinc peptidase implicated in ACS pathogenesis

Aug. 31, 2012

Biomarker has prognostic value in patients with diabetes and coronary artery disease

Aug. 29, 2012

Tenascin-C evaluated as a marker of isolated noncompaction cardiomyopathy

Aug. 29, 2012

Ten-gene molecular signature predicts response to cancer radiotherapy

Aug. 27, 2012

Scientists in Germany identify new resistance loci for severe malaria

Aug. 24, 2012

New mutation linked to persistent hyperplasia of the primary vitreous

Aug. 21, 2012

New cause identified of severe X-linked retinitis pigmentosa

Aug. 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...